OVAREX
associated with 12 other trademarks
ovarian cancer vaccine based on a murine monoclonal antibody and an ovarian cancer pharmaceutical preparation for vaccination consisting of the monocl...

Words that describe this trademark:

murine monoclonal antibody  ovarian cancer vaccine  monoclonal antibody  pharmaceutical preparation  ovarian cancer  cancer vaccine  based  antibody  vaccine  cancer 

Serial Number:

74617224

Mark:

OVAREX

Status:

Cancelled-Section 8

Status Date:

06-24-2011

Filing Date:

Registration Number:

2406495

Registration Date:

11-21-2000

Goods and Services:

ovarian cancer vaccine based on a murine monoclonal antibody and an ovarian cancer pharmaceutical preparation for vaccination consisting of the monoclonal antibody supplied in a proprietary formulation for intravenous, subcutaneous, intraperitoneal or intramuscular injection in humans

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

12-28-1999

Mark Drawing Status:

Typed Drawing

Abandon Date:

N/A

Business Name:

HOLLAND & HART LLP

Correspondent Name:

Recent Trademark filings by this company